Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world’s largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child’s own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57707-cord-blood-registry-stem-cell-trials-child-autism
Today's SUVs and pickups pose far less risk to people in cars and minivans than previous generations, a new study from the Insurance Institute for Highway Safety shows. Until recently, SUVs and pickups were more likely than cars or minivans of the same weight to be involved in crashes that killed occupants of other cars or minivans. That's no longer the case for SUVs, and for pickups the higher risk is much less pronounced than it had been.
Equal parts travelogue, character study, and global documentary, The Meeting of the Waters is for any Christian leader or layperson eager to make a difference in a changing world. Identifies seven trends having a major impact on the Church around the world-and on every Christian at home in every country.The Meeting of the Waters by Fritz Kling Find out more about this author and book here- http://tinyurl.com/ybcdv8d Christian Ministry
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
As recent graduates pour into a workplace brimming with older employees, cross-generational dynamics are rife with age stereotypes. But are these stereotypes scientifically valid? A new study by the international training and consulting firm AchieveGlobal found they are not.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/achieveglobal/48875/
Caralluma
Fimbriata is widely acknowledged as the MOST POWERFUL weight loss and
appetite suppressant that is completely natural and 100% side effect
free! To learn all about Caralluma and what it means for YOU CLICK http://carallumaforyou.com/ To learn about the bestselling Caralluma product CLICK http://carallumaforyou.com/caralluma-actives
Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53686-cord-blood-childrens-memorial-hermann-fda-approved-stem-cells-hearing-loss
Nearly five black women die needlessly per day from breast cancer in the United States – a total of 1,722 deaths annually – according to a study released today at the Avon Foundation Breast Cancer Forum and simultaneously published in Cancer Epidemiology. The 2012 Racial Disparity in Breast Cancer Mortality Study found that 21 of the 25* largest U.S. cities have a black: white disparity in breast cancer mortality, 13 of which are statistically significant.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52895-avon-foundation-breast-cancer-forum-racial-disparity-mortality-study
Scottish Widows - Pension Report. Ian Naismith, Head of Pensions Development at Scottish Widows talks us through the the current problem with pensions in 2010. Scottish Widows conducted a study where members of the public are asked how they are saving for the future and wether they are worried. The Scottish Widows report showed a worrying 41% of people are saving less whilst 21% save nothing.
A study conducted by researchers from the University of L’Aquila in Italy and Mars, Incorporated provides compelling new evidence that the regular consumption of dietary cocoa flavanols may improve cognitive function in elderly subjects with early memory decline. Just published online in the journal Hypertension, this current study significantly advances understanding of the benefits of flavanols by specifically exploring the impact of regular cocoa flavanol consumption on cognitive function in a population with Mild Cognitive Impairment (MCI). Previous research has suggested that the benefits of cocoa flavanols could extend to the brain. However, these studies were either only short-term or did not demonstrate a consistent cognitive benefit. This unique study addresses this gap and provides important insights into the possibility of slowing or even reversing cognitive declines associated with aging through consumption of these natural compounds.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/marsincorporated/56580/
Today, a new study from P&G Beauty & Grooming and lead investigator Nancy Etcoff, PhD., Assistant Clinical Professor at Harvard University and Associate Researcher at Massachusetts General Hospital Department of Psychiatry, confirms for the first time that using color cosmetics does, in fact, significantly alter how women are perceived by others, at first glance and over time. Results of the study, published on October 3, 2011 in PLoS ONE, show that makeup application specifically impacts judgments of attractiveness and character when viewed rapidly or for unlimited amounts of time.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52087-p-g-harvard-study-reveals-cosmetics-alter-instinctual-perception
